Engineered receptor-biased IL-2-drug immunoconjugates selectively expand Tregs and suppress effector cells for autoimmune therapy. (linkinghub.elsevier.com)

Authors: Li J … Zhang B Journal: Cell Reports Medicine Published: 2026-10-30 DOI: https://doi.org/10.1016/j.xcrm.2026.103127